Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rosenbaum JN"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase.
Autorzy:
Eyerer FIR; From the Department of Pathology and Laboratory Medicine, University of Vermont Medical Center; Burlington (Eyerer).
Bradshaw G; Proficiency Testing, College of American Pathologists, Northfield, Illinois (Bradshaw, Vasalos).
Vasalos P; Proficiency Testing, College of American Pathologists, Northfield, Illinois (Bradshaw, Vasalos).
Laser JS; Everly Health; Austin, Texas (Laser).
Chang CC; AdventHealth-Orlando, Orlando, Florida (Chang).; Department of Pathology, College of Medicine, University of Central Florida, Orlando (Chang).
Kim AS; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts (Kim).
Olson DR; Department of Pathology and Laboratory Medicine, Children's Minnesota, Minneapolis (Olson).
Paler RJ; Labcorp Oncology, Laboratory Corporation of America Holdings, Phoenix, Arizona (Paler).
Rosenbaum JN; Department of Pathology, Kaiser Permanente, San Jose, California (Rosenbaum).
Walk EE; Department of Medical, Regulatory and Clinical Affairs, PathAI, Boston, Massachusetts (Walk).
Willis JE; Department of Pathology, Case Western Reserve University/Cleveland Medical Center, Cleveland, Ohio (Willis).
Yao J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Yao).
Yohe SL; The Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis (Yohe).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2023 Aug 01; Vol. 147 (8), pp. 872-884.
Typ publikacji:
Journal Article
MeSH Terms:
Receptor, trkA*/genetics
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/drug therapy
Humans ; Receptor, trkC/genetics ; In Situ Hybridization, Fluorescence ; Laboratories ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms.
Autorzy:
Sussman RT; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Oran AR; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Paolillo C; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Lieberman D; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Morrissette JJD; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Rosenbaum JN; From the Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2020 Jan; Vol. 144 (1), pp. 90-98. Date of Electronic Publication: 2019 Jun 18.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
High-Throughput Nucleotide Sequencing/*methods
Oncogene Proteins, Fusion/*analysis
Sequence Analysis, RNA/*methods
Humans ; Multiplex Polymerase Chain Reaction/methods ; Protein Isoforms/analysis
Czasopismo naukowe
Tytuł:
Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas.
Autorzy:
Viaene AN; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Lee EB; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Rosenbaum JN; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Nasrallah IM; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Nasrallah MP; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. .; Hospital of the University of Pennsylvania, FO6.089 3400 Spruce St, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2019 May 02; Vol. 7 (1), pp. 69. Date of Electronic Publication: 2019 May 02.
Typ publikacji:
Journal Article
MeSH Terms:
Pituitary Neoplasms/*metabolism
Pituitary Neoplasms/*pathology
Adult ; Aged ; Biomarkers, Tumor/metabolism ; Female ; Humans ; Immunohistochemistry ; MAP Kinase Signaling System ; Male ; Middle Aged ; Proto-Oncogene Proteins B-raf/metabolism
Czasopismo naukowe
Tytuł:
Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma).
Autorzy:
Rush PS; Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Rosenbaum JN; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Roy M; Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Baus RM; Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Bennett DD; Department of Dermatology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Lloyd RV; Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2018 Feb; Vol. 45 (2), pp. 129-135. Date of Electronic Publication: 2017 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*analysis
Carcinoma, Merkel Cell/*pathology
Repressor Proteins/*biosynthesis
Skin Neoplasms/*pathology
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Repressor Proteins/analysis
Czasopismo naukowe
Tytuł:
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Autorzy:
Duncavage E; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); Blood and Marrow Transplantation, the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Advani RH
Agosti S
Foulis P
Gibson C
Kang L
Khoury JD
Medeiros LJ
Ohgami RS
O'Malley DP
Patel KP
Rosenbaum JN
Wilson C
Pokaż więcej
Corporate Authors:
Members of the Cancer Biomarker Reporting Committee, College of American Pathologists
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Nov; Vol. 140 (11), pp. 1228-1230. Date of Electronic Publication: 2016 Apr 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
Autorzy:
Duncavage E; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Advani RH; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Agosti S; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Foulis P; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Gibson C; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Kang L; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Khoury JD; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Medeiros LJ; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Ohgami RS; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
O'Malley DP; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Patel KP; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Rosenbaum JN; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Wilson C; From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri (Drs Duncavage and Rosenbaum); the Departments of Medicine, Oncology Division (Dr Advani), and Pathology (Dr Ohgami), Stanford University Medical Center, Stanford, California; the Pathology & Laboratory Medicine Service, James A. Haley Veterans Affairs Medical Center, Tampa, Florida (Drs Agosti, Foulis, and Kang); the Moffitt Cancer Center, Tampa, Florida (Ms Gibson); the Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston (Drs Khoury, Medeiros, and Patel); the Department of Pathology, Clarient Pathology Services, Aliso Viejo, California (Dr O'Malley); and the Department of Hematopathology, University of New Mexico Health Sciences Center, Albuquerque (Dr Wilson).
Pokaż więcej
Corporate Authors:
Members of the Cancer Biomarker Reporting Committee, College of American Pathologists
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Nov; Vol. 140 (11), pp. 1225-1227. Date of Electronic Publication: 2016 Apr 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic.
Autorzy:
Rosenbaum JN; Department of Anesthesiology, Northwestern University Feinberg School of Medicine, 303 E, Chicago Avenue, Ward 10-070, Chicago, IL 60611, USA.
Duggan A
García-Añoveros J
Pokaż więcej
Źródło:
Neural development [Neural Dev] 2011 Feb 01; Vol. 6, pp. 6. Date of Electronic Publication: 2011 Feb 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA-Binding Proteins/*metabolism
Gene Expression Regulation, Developmental/*physiology
Neural Stem Cells/*physiology
Neurogenesis/*genetics
Olfactory Pathways/*cytology
Transcription Factors/*metabolism
Age Factors ; Animals ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Basic Helix-Loop-Helix Transcription Factors/metabolism ; Body Patterning/genetics ; Bromodeoxyuridine/metabolism ; Cell Count/methods ; Cell Cycle/drug effects ; Cell Cycle/genetics ; Cell Differentiation ; Cell Proliferation/drug effects ; DNA-Binding Proteins/deficiency ; DNA-Binding Proteins/genetics ; Dopamine Agents/pharmacology ; Embryo, Mammalian ; Gene Expression Regulation, Developmental/genetics ; Ki-67 Antigen/metabolism ; Levodopa/pharmacology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microscopy, Electron, Transmission/methods ; Mutation/genetics ; Neural Stem Cells/drug effects ; Neural Stem Cells/ultrastructure ; Neurogenesis/drug effects ; Olfactory Pathways/embryology ; Olfactory Pathways/metabolism ; Repressor Proteins ; Transcription Factors/deficiency ; Transcription Factors/genetics
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies